Mobile cardiology during the COVID-19 outbreak.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. QoS-Aware Smart Phone-Based User Tracking Application to Prevent Outbreak of COVID-19 in Saudi Arabia.Computational intelligence and neuroscience · 2022
   Article
2. The post-pandemic legacy: the breakthrough of digital health and telemedicine.Cardiovascular research · 2021
   Article
3. Highlights of American Heart Association Scientific Sessions 2020: a virtual experience.Cardiovascular research · 2021
   Article
4. The impact of COVID-19 on cardiology departments.Archives of medical sciences. Atherosclerotic diseases · 2021
   Article

Corrections and comments

• Comment on
  Rapid implementation of mobile technology for real-time epidemiology of COVID-19.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as